Harima et al 2022 - comparison of duodenal stenting and gastrojejunostomy for duodenal obstruction with biliary obstruction.The present study aimed to compare clinical outcomes between dus and gj in patients with double obstruction who underwent biliary stenting.The present study further aimed to analyze the risk factors associated with survival time and time to recurrent biliary obstruction (trbo) dus was performed using evolution duodenal stent; 22-mm diameter,was performed either with an open or laparoscopic approach based on the description of performing surgeons.Biliary stenting was performed with the ptbd approach, ercp approach or eus-bd approach based on the description of the performing physicians.For the ptbd approach, an uncovered 10-mm-diameter sems (epic biliary stent; boston scientific) was placed after temporary external drainage.For the ercp approach, a covered or an uncovered 10-mm-diameter sems was placed, and when eus-guided hepaticogastrostomy combined with antegrade stenting (eus-hgas) was performed, an uncovered 10-mm-diameter sems (zilver stent; cook medical or niti- s large cell sr slim delivery; taewoong medical) and a dedicated 8-fr plastic stent were placed.This complaint was opened to capture stent migration.As per clinical input 'require intervention/additional procedures.' 84 underwent dus.Age 72.Male, n 39(46.4%).
|
Pma/510(k) # k163468.Device evaluation: the device evaluation for evolution duodenal device of unknown lot could not be completed as the device or photographic evidence of the device was not returned for evaluation.This file is related to (b)(4) (3001845648-2023-00035), (b)(4) (3001845648-2023-00037), (b)(4) (3001845648-2023-00038), and (b)(4) (3001845648-2023-00039).(b)(4) was opened to capture stent migration.Manufacturing records: prior to distribution all devices are subjected to a visual inspection and functional inspection to ensure device integrity.Manufacturing records review could not be completed as the lot number is unknown.Review historical data: historical data was not reviewed as the lot number is unknown.Instructions for use and/label the instructions for use, ifu0053 which accompanies this device, states ¿additional complications include but are not limited to: pancreatitis, intestinal perforation, pain, inadequate expansion, stent misplacement and/or migration, tumour ingrowth or overgrowth, stent occlusion, ulcerations, pressure necrosis, necrosis of the luminal mucosa, septicaemia, foreign body sensation, bowel impaction, death (other than due to normal disease progression).There is no evidence to suggest that the customer did not follow the instructions for use.Root cause analysis: a definitive root cause could not be determined however a possible root cause can be attributed to known potential complications.The instructions for use lists stent migration as a potential complication following the placement of this device.Summary of investigation: according to the literature study one complication of stent migration occurred.Confirmed quantity of 1 device, confirmed used.The patients required intervention investigation findings concludes a definitive root cause could not be determined however a possible root cause can be attributed to known potential complications.The instructions for use lists stent migration as a potential complication following the placement of this device.Complaint is confirmed based on customer and/or rep testimony.Complaints of this nature will continue to be monitored for potential emerging trends.
|